SPONSOR
Shanghai Junshi Bioscience Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 3
Conditions studied: Triple-negative Breast CancerAdvanced NSCLCPrimary Hypercholesterolaemia and Mixed Dyslipidemia
Shanghai Junshi Bioscience Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Triple-negative Breast Cancer, Advanced NSCLC, Primary Hypercholesterolaemia and Mixed Dyslipidemia.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Junshi Bioscience Co., Ltd.
How many clinical trials has Shanghai Junshi Bioscience Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Shanghai Junshi Bioscience Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Triple-negative Breast Cancer, Advanced NSCLC, Primary Hypercholesterolaemia and Mixed Dyslipidemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Junshi Bioscience Co., Ltd. research focus on?
Shanghai Junshi Bioscience Co., Ltd. clinical trials span Triple-negative Breast Cancer, Advanced NSCLC, Primary Hypercholesterolaemia and Mixed Dyslipidemia. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Junshi Bioscience Co., Ltd. clinical trial?
To participate in a Shanghai Junshi Bioscience Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Junshi Bioscience Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shanghai Junshi Bioscience Co., Ltd.
NCT07045311 Phase 2
Recruiting
JS207 Combination Therapy in Triple-negative Breast Cancer
Triple-negative Breast Cancer
NCT06924606 Phase 2
Recruiting
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Advanced NSCLC
NCT05621070 Phase 3
Recruiting
Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Primary Hypercholesterolaemia and Mixed Dyslipidemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology